This topic contains a solution. Click here to go to the answer

Author Question: Who or what killed TIPS? a. Congress c. The PATRIOT Act b. Homeland Security d. Media ... (Read 164 times)

MirandaLo

  • Hero Member
  • *****
  • Posts: 538
Who or what killed TIPS?
 
  a. Congress c. The PATRIOT Act b. Homeland Security d. Media outrage

Question 2

What is a major factor in driving data surveillance forward?
 
  a. The need for security c. The commodification of the military b. The need for control d. The commodification of personal information



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

31809pancho

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

ANS: A
The TIPS program was killed by Congress.



Answer to Question 2

ANS: D
According to Stanley and Steinhardt a major factor in driving data surveillance forward is the commodification of personal information by corporations.





MirandaLo

  • Member
  • Posts: 538
Reply 2 on: Jun 19, 2018
YES! Correct, THANKS for helping me on my review


31809pancho

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library